# Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

> **NCT06910306** · NA · RECRUITING · sponsor: **Alpha Tau Medical LTD.** · enrollment: 10 (estimated)

## Conditions studied

- Recurrent Glioblastoma
- Recurrent Gliomas

## Interventions

- **DEVICE:** Device :DaRT seeds

## Key facts

- **NCT ID:** NCT06910306
- **Lead sponsor:** Alpha Tau Medical LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2026-11-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06910306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06910306, "Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06910306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*